Biosite(R) Incorporated Reports New Option Grants Under NASDAQ Market Rule 4350
27 January 2006 - 3:00AM
PR Newswire (US)
SAN DIEGO, Jan. 26 /PRNewswire-FirstCall/ -- Biosite Incorporated
(NASDAQ:BSTE), today announced that, in accordance with NASDAQ
Marketplace Rule 4350, 49 non-officer employees were granted
inducement stock options covering an aggregate of 70,500 shares of
common stock. These options were granted pursuant to NASDAQ
Marketplace Rule 4350 (i)(1)(A)(iv) with the following terms: each
option has been classified as a non-qualified stock option, has an
exercise price equal to the fair market value on the grant date,
has a ten-year term, and vests in 16 equal quarterly installments
over four years (on each quarterly anniversary of the applicable
vesting commencement date). About Biosite Incorporated Biosite
Incorporated is a leading bio-medical company commercializing
proteomics discoveries for the advancement of medical diagnosis.
The Company's products contribute to improvements in medical care
by aiding physicians in the diagnosis of critical diseases and
health conditions. Biosite's Triage(R) rapid diagnostics are used
in approximately 50 percent of U.S. hospitals and in over 50
international markets. Information on Biosite can be found at
http://www.biosite.com/. Biosite(R) Triage(R) and New Dimensions in
Diagnosis(R) are registered trademarks of Biosite Incorporated. The
Company's logo is a trademark of Biosite Incorporated. FCMN
Contact: nbeckstrand@biosite.com DATASOURCE: Biosite Incorporated
CONTACT: Nadine Padilla, Vice President, Corporate & Investor
Relations of Biosite Incorporated, +1-858-455-4808, ext. 3187, Web
site: http://www.biosite.com/ Company News On-Call:
http://www.prnewswire.com/comp/116737.html
Copyright
Biosite (NASDAQ:BSTE)
Historical Stock Chart
From Jul 2024 to Jul 2024
Biosite (NASDAQ:BSTE)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Biosite (MM) (NASDAQ): 0 recent articles
More Biosite (MM) News Articles